These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33197050)

  • 61. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.
    Sahu A; Sninsky CA; Phelps CP; Dube MG; Kalra PS; Kalra SP
    Endocrinology; 1992 Dec; 131(6):2979-85. PubMed ID: 1446635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
    J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats.
    Mills RH; Sohn RK; Micevych PE
    J Neurosci; 2004 Jan; 24(4):947-55. PubMed ID: 14749439
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
    Soscia SJ; Harrington ME
    Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model.
    Campos EJ; Martins J; Brudzewsky D; Woldbye DPD; Ambrósio AF
    Ann Anat; 2020 Jan; 227():151419. PubMed ID: 31563570
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala.
    Wood J; Verma D; Lach G; Bonaventure P; Herzog H; Sperk G; Tasan RO
    Brain Struct Funct; 2016 Sep; 221(7):3373-91. PubMed ID: 26365505
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes.
    Chottová Dvoráková M; Wiegand S; Pesta M; Slavíková J; Grau V; Reischig J; Kuncová J; Kummer W
    Neuroscience; 2008 Feb; 151(4):1016-28. PubMed ID: 18201831
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats.
    Kuncová J; Svíglerová J; Tonar Z; Slavíková J
    Auton Neurosci; 2005 Aug; 121(1-2):7-15. PubMed ID: 15955747
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treadmill exercise suppresses diabetes-induced increment of neuropeptide Y expression in the hypothalamus of rats.
    Shin MS; Kim H; Chang HK; Lee TH; Jang MH; Shin MC; Lim BV; Lee HH; Kim YP; Yoon JH; Jeong IG; Kim CJ
    Neurosci Lett; 2003 Aug; 346(3):157-60. PubMed ID: 12853108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs.
    Morton KD; McCloskey MJ; Potter EK
    Regul Pept; 1999 May; 81(1-3):81-8. PubMed ID: 10395412
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
    dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
    Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of peptide tyrosine tyrosine (PYY3-36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats.
    Abdel-Hamid HA; Abdalla MMI; Zenhom NM; Ahmed RF
    Endocr Regul; 2019 Jan; 53(1):26-33. PubMed ID: 31517617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation.
    Chen SH; Cheung RT
    J Biomed Sci; 2004; 11(6):781-8. PubMed ID: 15591775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attenuation of pain-related behaviour evoked by carrageenan injection through blockade of neuropeptide Y Y1 and Y2 receptors.
    Kostić S; Puljak L; Sapunar D
    Eur J Pain; 2013 Apr; 17(4):493-504. PubMed ID: 23065815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.
    Rojas JM; Stafford JM; Saadat S; Printz RL; Beck-Sickinger AG; Niswender KD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1479-88. PubMed ID: 23074243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.